Opinion|Videos|November 28, 2024
Vitiligo Repigmentation Challenges and Evaluating Treatment Success
Author(s)Andrew F. Alexis, MD, MPH
Key Takeaways
- Sustained repigmentation in vitiligo is challenged by the disease's chronic nature and variability in patient response to treatments.
- Treatment success is evaluated by the extent and stability of repigmentation, patient satisfaction, and quality of life improvements.
The panelist discusses the primary challenges in vitiligo repigmentation, including maintaining patient compliance through lengthy treatment courses and managing expectations around partial repigmentation outcomes, which require careful monitoring and ongoing patient education about realistic goals while assessing success through standardized documentation of even minimal improvements to inform treatment adjustments.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the biggest challenges in achieving sustained repigmentation in vitiligo? How do you guide patients through these hurdles?
- How do you evaluate that treatment success when they’re only experiencing partial repigmentation?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Phase 2 Nemolizumab Trial Opens for CPUO
5
